SF Arzneimittel

SF Arzneimittel is a Berlin-based specialty pharmaceutical company that focuses on the development and distribution of niche medicinal products and value-added medicines. The company is particularly recognized for its presence in the central nervous system (CNS) therapeutic area, notably providing treatments for Attention Deficit Hyperactivity Disorder (ADHD) such as SF-Guanfacin. SF Arzneimittel emphasizes high-quality manufacturing and reliable supply chains to serve the German and European healthcare markets. Their business model revolves around identifying gaps in the market for specific formulations or off-patent molecules that require specialized expertise. By optimizing existing active ingredients for specific patient groups, particularly in pediatrics, the firm addresses unmet medical needs.